Abstract:ID 99907 Poster Board 509 Radiation poses a serious threat to active-duty military personnel, causing a multitude of health problems for those who are exposed, including the potential for radiation-induced cognitive decline. Recent studies have shown that metformin–an antidiabetic drug–could attenuate the cognitive decline following radiotherapy for brain tumors. Our study tested the hypothesis that metformin prophylaxis would attenuate the central nervous system (CNS) effects of a whole-body non-lethal radiation exposure dose more representative of an exposure military personnel might encounter. Female Long-Evans rats were injected with metformin (200 mg/kg per day) for 7 days prior to exposure to gamma radiation (2 Gy; 0.6 Gy/m) using the AFRRI high level cobalt facility. At 2 days following radiation exposure, the effects of metformin prophylaxis were assessed on serum chemistry, hematological endpoints, blood hormone levels, and markers of cell proliferation and neuroinflammation in different brain regions. In a separate group of rats, a behavioral battery was assessed from 7-30 days following radiation exposure, assessing recognition and spatial memory, and anxiety-like and depressive-like behaviors. Following behavioral testing, serum chemistry, hematological endpoints, and makers of cell proliferation and neuroinflammation in different brain regions were assessed. At the 2-day time point, 2 Gy gamma radiation significantly decreased white blood cells, lymphocytes, monocytes, and reticulocytes, with no effect of metformin. Metformin did prevent the radiation-induced decrease in uric acid at this time point. Further, metformin administration appears to have prevented the radiation-induced decrease in lactate, as well, but this effect did not achieve significance. At the 30-day time point, metformin administration significantly increased recovery of reticulocytes. We found a significantly decreased Glu/Gla osteocalcin ratio at 2 days following radiation in the metformin + radiation group compared to sham control. At 30 days following radiation exposure, there was a significant effect of radiation on the Glu/Gla osteocalcin ratio, with radiation exposure resulting in a significant decrease in this ratio compared to sham control rats. This suggests that the Glu/Gla osteocalcin ratio is potentially a biomarker of radiation exposure. Rats receiving metformin prophylaxis showed faster habituation in the open field test compared to all other groups. Taken together, metformin shows potential as prophylaxis for radiation-induced changes following a non-lethal dose of gamma radiation. Intramural funds (AFR-B2-12672) from the Armed Forces Radiobiology Research Institute.

Metformin ameliorates vanadium pentoxide or gamma irradiation-stimulated hepatotoxicity in male rats via targeting endoplasmic reticulum stress-induced apoptosis

Exploring the Potential of Metformin in Mitigating Radiation-induced Gastrointestinal and Hematopoietic System Injury in Rats After Whole-body X-ray Radiation: An Experimental Study

Metformin Ameliorates 2.856 GHz Microwave- Radiation-Induced Reproductive Impairments in Male Rats via Inhibition of Oxidative Stress and Apoptosis

Metformin Protects Against Radiation-Induced Pneumonitis and Fibrosis and Attenuates Upregulation of Dual Oxidase Genes Expression

Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization

Radioprotective effect of the anti-diabetic drug metformin

Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I

Evaluating the protective effect of metformin against diclofenac-induced oxidative stress and hepatic damage: In vitro and in vivo studies

Pretreatment with metformin protects mice from whole-body irradiation

Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation

Enhanced cytotoxic effect of low doses of metformin combined with ionizing radiation on hepatoma cells via ATP deprivation and inhibition of DNA repair.

Metformin as a Potential Countermeasure for the Central Nervous System Effects of Radiation Exposure

Metformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo

Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy

The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice

Metformin Enhances Radiation Response of ECa109 Cells Through Activation of ATM and AMPK

Metformin Protects ARPE-19 Cells from Glyoxal-Induced Oxidative Stress.

Involvement of Catalase in the Protective Benefits of Metformin in Mice with Oxidative Liver Injury.

Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells

Metformin Prevents Hyperglycemia-Associated, Oxidative Stress-Induced Vascular Endothelial Dysfunction: Essential Role for the Orphan Nuclear Receptor Human Nuclear Receptor 4A1 (Nur77)

Metformin attenuates myocardial ischemia-reperfusion injury via up-regulation of antioxidant enzymes